Medindia
Medindia LOGIN REGISTER
Advertisement

Covaris Announces Supply and Distribution Agreement with Applied Biosystems

Tuesday, November 13, 2007 General News
Advertisement
WOBURN, Mass., Nov. 13 Covaris Incorporated todayannounced that it has entered into a supply and distribution agreement withApplied Biosystems. As part of the agreement, Applied Biosystems will selland support Covaris(TM) S2 sample preparation instrument system for use withApplied Biosystems' recently launched next-generation genetic analysisplatform, the SOLiD(TM) System.
Advertisement

The Covaris sample preparation technology, which is based on its patentedAdaptive Focused Acoustic(TM) technology, brings speed and efficiency tobiological and chemical sample preparation.
Advertisement

The Covaris technology accelerates next-generation DNA sequencing samplepreparation. The technology involves bead handling, and fragment and mate-pair library compilation to accelerate bead reaction and DNA shearing, whichenables the generation of up to 35 base pairs of sequence data.

"Our relationship with Covaris has helped us to develop the most robust,accurate, and highest-throughput genetic analysis platform in the marketplacetoday to help our customers take advantage of the emerging applications fornext-generation DNA sequencing," said Kim Caple, vice president and generalmanager for Applied Biosystems' next-generation sequencing business. "Covarisprovides a reliable system for biological sample preparation that is anintegral part of the SOLiD System workflow."

According to Jim Laugharn, President and CEO of Covaris, "This agreementreflects the fundamental benefits the Covaris technology has for biologicaland chemical sample processing. For example, this versatile instrument can beused for both high intensity shearing of genomic DNA with one sample and forcontrolled, gentle mixing of enzymatic reaction beads in the next sample.

"Partnering with a life sciences industry leader such as AppliedBiosystems enables Covaris to continually bring advanced tools to the market,"said Laugharn.

About Covaris, Inc.

Covaris, Inc. is a rapidly growing life science instrument company. Itsproprietary instrument platform, based on patented Adaptive Focused Acoustic(AFA) technology brings unsurpassed speed and efficiency to biological andchemical sample preparation. The AFA process, based on shock wave physics,delivers controlled, precise, and accurate energy to biological and chemicalsamples. The process is non-contact, isothermal, and rapid. Leadingpharmaceutical and biotechnology companies worldwide are using Covarisinstruments for RNA extraction, Compound Dissolution, Drug Metabolism tissueextraction, and much more. Information about Covaris is available athttp://www.covarisinc.com.

Covaris, TissueTube, CryoPrep, Acoustics by Covaris, and Adaptive FocusedAcoustics are trademarks of Covaris, Inc. in the U.S. and/or certain othercountries.

SOURCE Covaris Incorporated
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close